PBYI Stock-Based Compensation
Puma Biotechnology Inc · Stock-Based Compensation
PBYI Stock-Based Compensation
Latest reported$1.95Mperiod ending
PBYI Quarterly Stock-Based Comp ($0.00 → $1.95M)
Quarterly stock-based compensation
High-resolution chart · PNG
PBYI stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 1,953,000 | |
| 1,896,000 | |
| 1,617,000 | |
| 1,673,000 | |
| 1,628,000 | |
| 2,026,000 | |
| 1,752,000 | |
| 2,054,000 | |
| 2,062,000 | |
| 2,377,000 | |
| 2,432,000 | |
| 2,545,000 | |
| 2,432,000 | |
| 2,838,000 | |
| 2,628,000 | |
| 2,830,000 | |
| 3,220,000 | |
| 3,148,000 | |
| 4,252,000 | |
| 4,282,000 | |
| 18,239,000 | |
| 5,860,000 | |
| 9,473,000 | |
| 7,565,000 | |
| 10,630,000 | |
| 8,907,000 | |
| 0 | |
| 12,213,000 | |
| 15,440,000 | |
| 18,138,000 | |
| 18,596,000 | |
| 20,807,000 | |
| 22,184,000 | |
| 25,352,000 | |
| 25,522,000 | |
| 26,491,000 | |
| 26,958,000 | |
| 29,764,000 | |
| 29,274,000 | |
| 29,751,000 | |
| 28,729,000 | |
| 29,510,000 | |
| 21,680,000 | |
| 24,957,000 | |
| 28,194,000 | |
| 20,103,000 | |
| 16,372,000 | |
| 10,449,000 | |
| 7,167,000 | |
| 5,163,000 | |
| 3,093,000 | |
| 1,806,000 | |
| 1,445,000 | |
| 1,175,000 | |
| 0 | |
| 6,924,000 | |
| 264,000 | |
| 198,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |